The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Can Drugs Be Used to Enhance the Psychotherapeutic Process?
Abstract
Many preindustrial cultures traditionally use certain psychedelic plants to enhance a procedure that resembles psychotherapy--an idea that was also tested in Western psychiatry in the 1950s and 1960s. LSD and related drugs were used to facilitate the production of memories, fantasies and insights and to enhance the therapeutic alliance. The results were inconclusive, and research was largely abandoned after the drugs became difficult to obtain. It may now be possible to revive this research, using new drugs that do not have some of the disadvantages of the old ones. The drug now of most interest is MDMA (3,4-methylenedioxymethamphetamine) a relatively mild and short-acting substance that is said to give a heightened capacity for introspection and intimacy without the perceptual changes, emotional unpredictability, and occasional adverse reactions associated with LSD. Therapists who have used the drug claim that it can enhance the therapeutic alliance by inviting self-disclosure and promoting trust. Whether MDMA fulfills this promise or not, other drugs may eventually prove useful in psychotherapy. Research on their potential should not be curtailed because of fear that they will be subject to illicit abuse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LSD-Assisted Psychotherapy in Patients with Terminal Cancer
Grof, S., Goodman, L. E., Richards, W. A., & Kurland, A. A. (2017) · International Pharmacopsychiatry · doi:10.1159/000467984 · Cited by 209
The psychedelic mystical experience in the human encounter with death
Pahnke, W. N. (1969) · Harvard Theological Review · doi:10.1017/s0017816000027577 · Cited by 147
Peyote in the Treatment of Alcoholism Among American Indians
ALBAUGH, B. J., & ANDERSON, P. O. (1974) · American Journal of Psychiatry · doi:10.1176/ajp.131.11.1247 · Cited by 128
Acute Adverse Reactions to Lsd in Clinical and Experimental use in the United Kingdom
Malleson, N. (1971) · British Journal of Psychiatry · doi:10.1192/bjp.118.543.229 · Cited by 111
Cited by
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
O'Hearn, E., Battaglia, G., De Souza, E., Kuhar, M., & Molliver, M. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02788.1988 · Cited by 542
Toxicity of amphetamines: an update
Carvalho, M., Carmo, H., Costa, V. M., Capela, J. P., Pontes, H., Remião, F., Carvalho, F., & Bastos, M. D. L. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0815-5 · Cited by 431
Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug
SOLOWIJ, N., HALL, W., & LEE, N. (1992) · British Journal of Addiction · doi:10.1111/j.1360-0443.1992.tb02003.x · Cited by 413
Effects of Schedule I drug laws on neuroscience research and treatment innovation
Nutt, D. J., King, L. A., & Nichols, D. E. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3530 · Cited by 337
Metadata
- Authors
- Grinspoon, L., & Bakalar, J. B.
- Venue
- American Journal of Psychotherapy
- Published
- 1986-07
- Volume
- 40
- Issue
- 3
- Pages
- 393-404
- ISSN
- 0002-9564 (ISSN-L)
- 2575-6559
- OpenAlex
- W2133416128
- Cited by
- 187
- References
- 4
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Can Drugs Be Used to Enhance the Psychotherapeutic Process? https://app.cochat.ai/papers/10.1176/appi.psychotherapy.1986.40.3.393
- The paper
- Grinspoon, L., & Bakalar, J. B. (1986). Can Drugs Be Used to Enhance the Psychotherapeutic Process? American Journal of Psychotherapy. https://doi.org/10.1176/appi.psychotherapy.1986.40.3.393
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.